Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Suzuki (Chiba, Japan), J. Ikari (Chiba, Japan), R. Anazawa (Chiba, Japan), N. Tanaka (Chiba, Japan), Y. Katsumata (Chiba, Japan), A. Shimada (Chiba, Japan), E. Suzuki (Chiba, Japan), K. Tatsumi (Chiba, Japan). Neutrophil extracellular traps contribute to pulmonary fibrosis induced by bleomycin. 2414

Member's Comments

No comment yet.

Related content which might interest you: Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Erythromycin inhibits neutrophil extracellular traps in smoking-related chronic pulmonary inflammation Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201 Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Extracellular matrix profile of lung in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017 Year: 2018 Role of NF-κB p50 in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006 Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Neutrophil extracellular traps promoted alveolar macrophages pyroptosis in LPS induced ALI/ARDS Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Danshenextract salt Inhibits bleomycin-induced experimental pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 Collagen VI-producing macrophages mediate lung fibrosis Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009